Lattice Biologics Participates in $300 Million Public-Private Initiative, the Advanced Regenerative Manufacturing Institute (ARMI)
SCOTTSDALE, AZ--(Marketwired - February 28, 2017) - Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCQB: LBLTF) ("Lattice Biologics" or the "Company") is pleased to announce that it is part of a new public-private initiative, the Advanced …